Oesophageal adenocarcinoma patients with a high CD8+ T cells density after NACT had a favorable clinical outcome [16], while the presence of Foxp3+ TILs in breast cancer patients predicted a good response to NACT and a favorable prognosis [17]. This evidence concerns the gene CD8A and esophageal adenocarcinoma.